📣 VC round data is live. Check it out!

Encompass Health Valuation Multiples

Discover Encompass Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Max Healthcare Institute, Mayapada Hospital, Bangkok Dusit Medical Services, Universal Health Services and more.

Encompass Health Overview

About Encompass Health

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.


Founded

1984

HQ

United States

Employees

40.1K

Financials (LTM)

Revenue: $6B
EBITDA: $1B

EV

$13B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Encompass Health Financials

Encompass Health reported last 12-month revenue of $6B and EBITDA of $1B.

In the same LTM period, Encompass Health generated $1B in EBITDA and $580M in net income.

Revenue (LTM)


Encompass Health P&L

In the most recent fiscal year, Encompass Health reported revenue of $6B and EBITDA of $1B.

Encompass Health is profitable as of last fiscal year, with gross margin of 96%, EBITDA margin of 24%, and net margin of 10%.

See analyst estimates for Encompass Health
LTMLast FY202320242025202620272028
Revenue$6B$6B$5B$5B$6B
Gross Profit-$6B$5B$5B$6B
Gross Margin-96%95%96%96%
EBITDA$1B$1B$1B$1B$1B
EBITDA Margin21%24%21%22%24%
EBIT Margin16%18%15%16%18%
Net Profit$580M$566M$352M$456M$566M
Net Margin9%10%7%8%10%
Net Debt-$2B---

Financial data powered by Morningstar, Inc.

Encompass Health Stock Performance

Encompass Health has current market cap of $10B, and enterprise value of $13B.

Market Cap Evolution


Encompass Health's stock price is $102.73.

Encompass Health share price decreased by 2.9% in the last 30 days, and by 16.2% in the last year.

Encompass Health has an EPS (earnings per share) of $5.71.

See more trading valuation data for Encompass Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13B$10B-2.9%-2.9%6.2%-16.2%$5.71

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Encompass Health Valuation Multiples

Encompass Health trades at 2.1x EV/Revenue multiple, and 9.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Encompass Health

EV / Revenue (LTM)


Encompass Health Financial Valuation Multiples

As of June 2, 2026, Encompass Health has market cap of $10B and EV of $13B.

Encompass Health has a P/E ratio of 17.6x.

LTMLast FY202320242025202620272028
EV/Revenue2.1x2.2x2.7x2.4x2.2x
EV/EBITDA9.8x9.2x12.6x10.8x9.2x
EV/EBIT13.5x12.2x17.6x14.9x12.2x
EV/Gross Profit-2.3x2.8x2.5x2.3x
P/E17.6x18.0x29.0x22.4x18.0x
EV/FCF19.6x15.7x48.1x35.7x29.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Encompass Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Encompass Health Margins & Growth Rates

Encompass Health grew revenue by 8% but EBITDA decreased by 2% in the last fiscal year.

In the most recent fiscal year, Encompass Health reported gross margin of 96%, EBITDA margin of 24%, and net margin of 10%.

See estimated margins and future growth rates for Encompass Health

Encompass Health Margins

Last FY202420252026202720282029
Gross Margin96%96%96%-
EBITDA Margin24%22%24%21%
EBIT Margin18%16%18%16%
Net Margin10%8%10%10%
FCF Margin14%7%7%7%

Encompass Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%12%10%8%
Gross Profit Growth-12%11%-
EBITDA Growth(2%)16%18%(2%)
EBIT Growth(5%)18%22%(5%)
Net Profit Growth8%29%24%8%
FCF Growth(47%)35%22%(2%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Encompass Health Operational KPIs

Encompass Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Encompass Health's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Encompass Health's Rule of X is 42% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Encompass Health
LTMLast FY202320242025202620272028
Rule of 4030%30%---
Bessemer Rule of X42%42%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
G&A Expenses to Revenue3%57%60%59%57%
Opex to Revenue-78%80%79%78%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Encompass Health Competitors

Encompass Health competitors include Max Healthcare Institute, Mayapada Hospital, Bangkok Dusit Medical Services, Universal Health Services, DaVita, Apollo Hospitals, Aier EYE Hospital Group, Fortis Healthcare, PureHealth and Ramsay Health.

Most Encompass Health public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Max Healthcare Institute11.2x10.4x36.9x35.5x
Mayapada Hospital66.9x-696.3x-
Bangkok Dusit Medical Services2.5x2.5x10.5x10.5x
Universal Health Services0.8x0.8x5.0x5.2x
DaVita1.8x1.8x8.8x8.7x
Apollo Hospitals4.9x4.8x30.8x31.9x
Aier EYE Hospital Group3.9x3.7x13.3x12.8x
Fortis Healthcare8.0x7.8x34.3x33.9x

This data is available for Pro users. Sign up to see all Encompass Health competitors and their valuation data.

Start Free Trial

Acquisitions by Encompass Health

Encompass Health has acquired 4 companies to date.

Last acquisition by Encompass Health was on April 26th 2021. Encompass Health acquired Frontier Home Health and Hospice for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Encompass Health

Frontier Home Health and Hospice
Camellia Healthcare
Reliant Hospital Partners
Encompass Home Health
Description
Frontier Home Health and Hospice is a Wyoming-based provider of home health and hospice care services supporting communities in the Rocky Mountain region.
Camellia Healthcare is a Hattiesburg-headquartered provider of Medicare-certified home health, hospice, and private duty nursing services across Mississippi, Alabama, Louisiana, and Tennessee. Operating fourteen home health agencies, eighteen hospice locations, and two private duty sites, the company delivers skilled nursing, therapy, and palliative care to patients in rural and urban counties.
Reliant Hospital Partners is a Nashville-headquartered management company overseeing long-term acute care hospitals and inpatient rehabilitation facilities across the United States. It operates LTACHs in Texas, Louisiana, and Oklahoma, providing specialized care for medically complex patients requiring extended ventilator weaning, wound care, and infectious disease management. The firm partners with hospitals like HCA Healthcare and collaborates with physicians trained in critical care pulmonology. Reliant Hospital Partners emphasizes outcomes-based care with average patient lengths of stay exceeding 25 days and high discharge-to-home rates.
Encompass Home Health is a Medicare-certified home health agency delivering skilled nursing, therapy, hospice, and pediatric care across twelve U.S. states from more than 100 branches. Headquartered in Dallas, Texas, it emphasizes technology-enabled care coordination for chronic conditions, post-acute recovery, and end-of-life support, serving patients through integrated electronic health records and telehealth platforms.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Bozeman, MT
Hattiesburg, MS
Dallas, TX
Dallas, TX
Deal Date26 Apr 202115 Mar 20181 Oct 201524 Nov 2014
Valuationundisclosed$140M$730M$750M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Encompass Health acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Encompass Health

When was Encompass Health founded?Encompass Health was founded in 1984.
Where is Encompass Health headquartered?Encompass Health is headquartered in United States.
How many employees does Encompass Health have?As of today, Encompass Health has over 40K employees.
Who is the CEO of Encompass Health?Encompass Health's CEO is Mark J. Tarr.
Is Encompass Health publicly listed?Yes, Encompass Health is a public company listed on NYSE.
What is the stock symbol of Encompass Health?Encompass Health trades under EHC ticker.
When did Encompass Health go public?Encompass Health went public in 1989.
Who are competitors of Encompass Health?Encompass Health main competitors include Max Healthcare Institute, Mayapada Hospital, Bangkok Dusit Medical Services, Universal Health Services, DaVita, Apollo Hospitals, Aier EYE Hospital Group, Fortis Healthcare, PureHealth, Ramsay Health.
What is the current market cap of Encompass Health?Encompass Health's current market cap is $10B.
What is the current revenue of Encompass Health?Encompass Health's last 12 months revenue is $6B.
What is the current revenue growth of Encompass Health?Encompass Health revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Encompass Health?Current revenue multiple of Encompass Health is 2.1x.
What is the current EBITDA of Encompass Health?Encompass Health's last 12 months EBITDA is $1B.
What is Encompass Health's EBITDA margin?Encompass Health's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Encompass Health?Current EBITDA multiple of Encompass Health is 9.8x.
What is the current FCF of Encompass Health?Encompass Health's last 12 months FCF is $655M.
What is Encompass Health's FCF margin?Encompass Health's last 12 months FCF margin is 11%.
What is the current EV/FCF multiple of Encompass Health?Current FCF multiple of Encompass Health is 19.6x.
How many companies Encompass Health has acquired to date?As of June 2026, Encompass Health has acquired 4 companies.
What was the largest acquisition by Encompass Health?$750M acquisition of Encompass Home Health on 24th November 2014 was the largest M&A Encompass Health has done to date.
What companies Encompass Health acquired?Encompass Health acquired Encompass Home Health, Reliant Hospital Partners, Camellia Healthcare, and Frontier Home Health and Hospice.
In how many companies Encompass Health has invested to date?Encompass Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Encompass Health

Lists including Encompass Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial